Akoya Biosciences Share Price Today
(NASDAQ: AKYA)

Name: Akoya Biosciences Share Price Today (NASDAQ: AKYA) - Akoya Biosciences Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Akoya Biosciences share price is $1.61 & ₹140.02 as on 6 Mar 2025, 2.30 'hrs' IST

$1.61

▲

-0.01

(-0.62%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Akoya Biosciences share price in Dollar and Rupees. Guide to invest in Akoya Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Akoya Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Akoya Biosciences share price movements

Today's Low: $1.56
Today's High: $1.69
$1.61
3.11%
Downside
Day's Volatility :7.69%
Upside
4.73%
52 Weeks Low: $1.55
52 Weeks High: $5.68
$1.61
3.73%
Downside
52 Weeks Volatility :72.71%
Upside
71.65%

Akoya Biosciences (AKYA) Returns

Period	Akoya Biosciences Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-21.74%	2.1%	0.0%
6 Months	-31.93%	-4.1%	0.0%
1 Year	-67.34%	2.2%	0.0%
3 Years	-83.8%	11.8%	-11.6%

Akoya Biosciences (AKYA) Key Statistics

in dollars & INR

Previous Close	$1.62
Open	$1.58
Today's High	$1.69
Today's Low	$1.56
Market Capitalization	$76.8M
Today's Volume	$138.7K
52 Week High	$5.68
52 Week Low	$1.55
Revenue TTM	$86.8M
EBITDA	$-36.4M
Earnings Per Share (EPS)	$-1.16
Profit Margin	-66.77%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-153.34%

How to invest in Akoya Biosciences Stock (AKYA) from India?

It is very easy for Indian residents to invest directly in Akoya Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Akoya Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Akoya Biosciences or AKYA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Akoya Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Akoya Biosciences shares which would translate to 0.540 fractional shares of Akoya Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Akoya Biosciences, in just a few clicks!

Returns in Akoya Biosciences (AKYA) for Indian investors in Rupees

The Akoya Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Akoya Biosciences investment value today

Current value as on today

₹37,422

Returns

₹62,578

(-62.58%)

Returns from Akoya Biosciences Stock

₹67,540 (-67.54%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Akoya Biosciences (AKYA)

-58%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Akoya Biosciences Stock from India on INDmoney has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Akoya Biosciences

Blue Water Life Science Advisors, LLC
9.48%
BlackRock Inc
3.30%
Vanguard Group Inc
2.84%
PARAGON Assoc & PARAGON Assoc II JV
1.62%
Geode Capital Management, LLC
1.14%
BP WEALTH MANAGEMENT, LLC
1.04%

Analyst Recommendation on Akoya Biosciences

Buy

85%Buy

14%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Akoya Biosciences(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Akoya Biosciences Stock (AKYA)

What analysts predicted

Upside of 123.6%

Target:

$3.60

Current:

$1.61

Insights on Akoya Biosciences Stock (Ticker Symbol: AKYA)

Price Movement
In the last 1 month, AKYA stock has moved down by -40.0%
Decreasing Revenue
Revenue is down for the last 2 quarters, 23.16M → 18.81M (in $), with an average decrease of 18.8% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -23.48M → -10.53M (in $), with an average increase of 51.7% per quarter
AKYA vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 44.1% return, outperforming this stock by 112.3%
AKYA vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 84.6% return, outperforming this stock by 168.5%
Price to Sales
ForAKYA every $1 of sales, investors are willing to pay $0.9, whereas for Intuitive Surgical, Inc., the investors are paying $23.7 for every $1 of sales.

AKYA Akoya Biosciences Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$42.2M	-
Net Income	$-14.8M	-
Net Profit Margin	-34.93%	-

	FY20	Y/Y Change
Revenue	$42.4M	↑ 0.49%
Net Income	$-16.7M	↑ 13.25%
Net Profit Margin	-39.36%	↓ 4.43%

	FY21	Y/Y Change
Revenue	$54.9M	↑ 29.39%
Net Income	$-42.9M	↑ 157.0%
Net Profit Margin	-78.18%	↓ 38.82%

	FY22	Y/Y Change
Revenue	$74.9M	↑ 36.31%
Net Income	$-70.6M	↑ 64.53%
Net Profit Margin	-94.37%	↓ 16.19%

	FY23	Y/Y Change
Revenue	$96.6M	↑ 29.09%
Net Income	$-63.3M	↓ 10.36%
Net Profit Margin	-65.53%	↑ 28.84%

	Q2 FY23	Q/Q Change
Revenue	$23.5M	↑ 9.86%
Net Income	$-20.8M	↑ 10.64%
Net Profit Margin	-88.44%	↓ 0.62%

	Q3 FY23	Q/Q Change
Revenue	$25.2M	↑ 7.2%
Net Income	$-12.9M	↓ 37.91%
Net Profit Margin	-51.22%	↑ 37.22%

	Q4 FY23	Q/Q Change
Revenue	$26.5M	↑ 5.04%
Net Income	$-10.8M	↓ 16.37%
Net Profit Margin	-40.78%	↑ 10.44%

	Q1 FY24	Q/Q Change
Revenue	$18.4M	↓ 30.72%
Net Income	$-23.5M	↑ 117.4%
Net Profit Margin	-127.98%	↓ 87.2%

	Q2 FY24	Q/Q Change
Revenue	$23.2M	↑ 26.23%
Net Income	$-13.1M	↓ 44.01%
Net Profit Margin	-56.76%	↑ 71.22%

	Q3 FY24	Q/Q Change
Revenue	$18.8M	↓ 18.78%
Net Income	$-10.5M	↓ 19.9%
Net Profit Margin	-55.98%	↑ 0.78%

	FY19	Y/Y Change
Profit	$24.7M	-

	FY20	Y/Y Change
Profit	$25.9M	↑ 5.05%

	FY21	Y/Y Change
Profit	$34.2M	↑ 32.08%

	FY22	Y/Y Change
Profit	$43.4M	↑ 26.8%

	FY23	Y/Y Change
Profit	$56.3M	↑ 29.76%

	Q2 FY23	Q/Q Change
Profit	$12.1M	↓ 1.44%

	Q3 FY23	Q/Q Change
Profit	$15.3M	↑ 26.08%

	Q4 FY23	Q/Q Change
Profit	$14.7M	↓ 3.47%

	Q1 FY24	Q/Q Change
Profit	$8.4M	↓ 43.18%

	Q2 FY24	Q/Q Change
Profit	$13.4M	↑ 59.76%

	Q3 FY24	Q/Q Change
Profit	$11.7M	↓ 12.42%

	FY19	Y/Y Change
Operating Cash Flow	$-13.8M	-
Investing Cash Flow	$-12.9M	-
Financing Cash Flow	$28.6M	-

	FY20	Y/Y Change
Operating Cash Flow	$-6.8M	↓ 50.33%
Investing Cash Flow	$6.7M	↓ 152.19%
Financing Cash Flow	$5.5M	↓ 80.79%

	FY21	Y/Y Change
Operating Cash Flow	$-36.1M	↑ 427.08%
Investing Cash Flow	$-5.1M	↓ 175.71%
Financing Cash Flow	$137.0M	↑ 2397.9%

	FY22	Y/Y Change
Operating Cash Flow	$-53.5M	↑ 48.32%
Investing Cash Flow	$-14.1M	↑ 176.38%
Financing Cash Flow	$28.7M	↓ 79.04%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-11.8M	↓ 40.26%
Investing Cash Flow	$-1.4M	↓ 122.97%
Financing Cash Flow	$46.3M	↓ 11156.56%

Akoya Biosciences Technicals Summary

Sell

Neutral

Buy

Akoya Biosciences is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Akoya Biosciences (AKYA) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Akoya Biosciences Inc	-40.88%	-31.93%	-67.34%	-83.8%	-93.78%
Intuitive Surgical, Inc.	-3.56%	17.05%	43.74%	90.63%	227.79%
Alcon Ag	2.42%	-1.93%	7.98%	27.22%	63.47%
Resmed Inc.	-3.77%	-5.43%	25.61%	-6.39%	49.83%
Becton, Dickinson And Company	-9.43%	-3.85%	-4.81%	-18.76%	-2.82%
Cooper Companies Inc., The	-4.9%	-14.86%	-10.99%	-9.6%	14.23%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Akoya Biosciences Inc	NA	NA	NA	-1.07	-1.53	-0.18	NA	0.28
Intuitive Surgical, Inc.	88.31	88.31	3.96	8.06	0.16	0.09	NA	46.08
Alcon Ag	45.92	45.92	2.8	3.27	0.05	0.03	0.0	43.58
Resmed Inc.	27.49	27.49	1.67	9.47	0.26	0.14	0.01	35.77
Becton, Dickinson And Company	38.47	38.47	1.04	14.42	0.07	0.04	0.02	87.78
Cooper Companies Inc., The	46.76	46.76	9.46	3.98	0.05	0.04	NA	40.5

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Akoya Biosciences Inc	Buy	$76.8M	-93.78%	NA	-66.77%
Intuitive Surgical, Inc.	Buy	$202.2B	227.79%	88.31	27.81%
Alcon Ag	Buy	$46.6B	63.47%	45.92	10.27%
Resmed Inc.	Buy	$34.2B	49.83%	27.49	25.35%
Becton, Dickinson And Company	Buy	$64.4B	-2.82%	38.47	8.37%
Cooper Companies Inc., The	Buy	$18.3B	14.23%	46.76	10.07%

About Akoya Biosciences

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients; and license agreement with NeraCare for the development and commercialization of the immunoprint test for early-stage melanoma patient treatment decisions. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Organization	Akoya Biosciences
Employees	330
CEO	Mr. Brian McKelligon
Industry	Healthcare

Management People of Akoya Biosciences

Name	Title
Mr. Brian McKelligon	President, CEO & Director
Mr. John Frederick Ek CPA	CFO, Principal Financial Officer & Principal Accounting Officer
Mr. Anthony Catalano	Senior Vice President of Operations
Mr. Priyam Shah	Senior Director of Business Development & Investor Relations Strategy
Ms. Jennifer Kamocsay	Chief Legal Officer
Dr. Niro Ramachandran Ph.D.	Chief Business Officer
Dr. Pascal Bamford Ph.D.	Senior Vice President of Research & Development and Laboratory Operations
Mr. Rob C. Hart CFA, J.D.	Secretary

Important FAQs about investing in AKYA Stock from India :

What is Akoya Biosciences share price today?

Akoya Biosciences share price today stands at $1.61, Open: $1.58 ; Previous Close: $1.62 ; High: $1.69 ; Low: $1.56 ; 52 Week High: $5.68 ; 52 Week Low: $1.55.

The stock opens at $1.58, after a previous close of $1.62. The stock reached a daily high of $1.69 and a low of $1.56, with a 52-week high of $5.68 and a 52-week low of $1.55.

Can Indians buy Akoya Biosciences shares?

Yes, Indians can invest in the Akoya Biosciences (AKYA) from India.

With INDmoney, you can buy Akoya Biosciences at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Akoya Biosciences at zero transaction cost.

How can I buy Akoya Biosciences shares from India?

It is very easy to buy Akoya Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Akoya Biosciences (AKYA) be purchased?

Yes, you can buy fractional shares of Akoya Biosciences with INDmoney app.

What are the documents required to start investing in Akoya Biosciences stocks?

To start investing in Akoya Biosciences, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.